NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Bearish flow noted in GSK (GSK) Pharma with 6,103 puts trading, or 5x expected. Most active are 3/14 weekly 39.5 puts and Mar-25 41.5 calls, with total volume in those strikes near 5,500 contracts.
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
After hours: March 14 at 7:47:25 PM EDT Loading Chart for GSK ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
After hours: 7:59:44 pm GMT-5 Loading Chart for GSK ...
After hours: March 13 at 7:58:06 p.m. EDT Loading Chart for GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results